Publications Database

Davis T. N. et al. (2013)

Chelation treatment for autism spectrum disorders: A systematic review.

Research in Autism Spectrum Disorders

7(1), pp. 49-55.

Read Abstract (New Window)

Defeat Autism Now! (2005)

Treatment options for mercury metal toxicity in autism and related developmental disabilities: Consensus position paper.

San Diego: CA: Autism Research Institute

Fido A. , Al-Saad S. (2005)

Toxic trace elements in the hair of children with autism.

Autism

9(3), pp. 290-298.

Read Abstract (New Window)

Fitzpatrick M. (2009)

Defeating autism: a damaging delusion.

London: Routledge

Geier D. A. et al. (2008)

Biomarkers of environmental toxicity and susceptibility in autism.

Journal of the Neurological Sciences

280(1), pp. 101-108

Read Abstract (New Window)

Goldman R. H. , Woolf A. (2012)

Chelation therapy: guidance for the general public.

Boston, MA: New England Pediatric Environmental Health Specialty Unit

Read Full (New Window)

Mercury Dextoxification Consensus Group (2005)

Mercury Detoxification Consensus Group Position Paper.

San Diego, CA: Autism Research Institute

Holmes A. S. , Blaxill M. F. , Haley B. (2003)

Reduced levels of mercury in first baby haircuts of autistic children.

International Journal of Toxicology

22(4), pp. 277-278.

Read Abstract (New Window)

Ip P. et al. (2004)

Mercury exposure in children with autistic spectrum disorder: case-control study.

Journal of Child Neurology

19(6), pp. 431-434.

Read Abstract (New Window)

James S. et al. (2015)

Chelation for autism spectrum disorder (ASD) (Review).

Cochrane Database of Systematic Reviews

(5),

Read Abstract (New Window) Read Full (New Window)

Kern J. K. et al. (2007)

Sulfhydryl-reactive metals in autism.

Journal of Toxicology and Environmental Health (Part A)

70(8), pp. 715-721.

Read Abstract (New Window)

Mandy W. P. L. , Lai M. (2016)

Annual research review: The role of the environment in the developmental psychopathology of autism spectrum condition.

Journal of Child Psychology and Psychiatry

57(3), pp. 271-292.

Read Abstract (New Window)

Nataf R. et al. (2006)

Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.

Toxicology and Applied Pharmacology

214 pp. 99-108.

Read Abstract (New Window)

National Capital Poison Center (2010)

Chelation: Therapy or 'Therapy'?

Washington, DC: National Capital Poison Center

Read Full (New Window)

Niederhofer H. (2007)

Treating autism pharmacologically: also tacrine might improve symptomatology in some cases.

Journal of Child Neurology

22(8), pp. 1054

Read Full (New Window)

Rossignol D. A. , Frye R. E. (2012)

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

Molecular Psychiatry

17 pp. 389-401

Read Full (New Window)

Siniscalco D. , Antonucci N. (2013)

Involvement of dietary bioactive proteins and peptides in autism spectrum disorders.

Current Peptide and Protein Science

December, 14(8), pp. 674-679.

Read Abstract (New Window)

Stokstad E. (2008)

Stalled trial for autism highlights dilemma of alternative treatments.

Science

321(5887), p. 326

Read Full (New Window)

Cancer Research UK (2007)

What is cellular zeolite?

London: Cancer Research UK

Read Full (New Window)

Whitehouse C. , Boullata J. , McCauley L. (2008)

The potential toxicity of artificial sweeteners.

AAOHN Journal

56(6), pp. 251-259

Read Abstract (New Window)